the biocomposite is based on the combination of a solid phase constituted by tricalcium β - phosphate , calcium oxide and zinc oxide which are combined with a liquid phase composed by a natural polymer such as chitosan . this combination provides osteopromoting properties . the compounds forming the solid phase , according to the present invention , are in the following ranges of weight percentage in relation to the total weight of said solid phase : the production procedure of the biocomposite consists in preparing different formulations varying the percentage of the composition in the solid phase and the liquid phase . the amounts of the components in the solid phase are weighed : tricalcium β - phosphate , calcium oxide and zinc oxide , are mixed for 5 minutes and dehydrated in a microwave oven . then , the necessary amount of chitosan is added and mixing is continued until obtaining a fluid paste . the solid phase is mostly dry tricalcium β - phosphate with a purity greater than 96 %, the other components used in this phase must have a purity greater than 98 %. the liquid phase is composed by natural polymer chitosan gel obtained from crustacean shell at 2 %. the chitosan gel is the binding elements of the product of the present invention and it is important in the moldable characteristics of the material . in theory , neutral or acid chitosan can be used . in this invention , chitosan dissolved in acetic acid was used , which is the form as normally used . fig3 shows the surroundings of the mixture and the regions for which the target ph value of 6 is obtained are reported , as well as the lines and black dots of the region described for the experimental samples , according to the present invention . such tests were performed at a temperature of 22 ° c . and a relative humidity of 100 %, the ph was measured when the solid phase and the liquid phase were combined and the ph measurements were taken every minute , during 45 minutes from the time in which the homogeneous mixture was obtained . three mixtures were prepared according to the present invention , which proportions for the solid phase are as follow : in all these , 3 g of chitosan were added as liquid phase . the preparation process of the biocomposite of the present invention according to the above examples comprises the following steps : 1 . weighing the amounts of zinc oxide , calcium oxide and tricalcium β - phosphate ; 2 . placing in a mixer the amounts previously weighed and mixing during a period of 5 to 15 minutes until obtaining a homogeneous combination of the components ; 3 . heating in a microwave oven , the mixture obtained in the step 2 , during a minute for its dehydration ; 4 . weighing the amount of chitosan gel ( liquid phase ) and adding it to the mixture of minerals obtained in step 3 ; 5 . mixing from 2 to 5 minutes the products in steps 3 and 4 in the mixer until obtaining the homogeneous preparation . the calculation for the proportions of the three components in the solid phase , was made through a quadratic model and it is shown in fig3 , wherein the surroundings of the mixture and the regions of the ph values required for the application are shown . it was surprisingly found that the compositions where the powder / liquid ratio is 0 . 67 have adequate physicochemical properties which allow its easy molding and a setting time convenient for the application thereof in bone cavities difficult to heal . the interval in which the solid phase to liquid phase ratio can range is from 0 . 5 to 0 . 9 . preferably , the solid phase to liquid phase ratio corresponds to 0 . 67 , which according to the examples provided in the present specification , is equivalent to 2 g of powder ( solid phase ) per 3 g of liquid phase . such proportion is fundamental because it provides the consistency of application necessary for the material to maintain “ in situ ” allowing thereby the moldability and the conformation of tissue without the dispersion of the product and without being affected by body fluids . in addition , the powder / liquid proportion is important because it guarantees the mechanical resistance ideal for supporting the load made by the comprehensive and tensional forces generated during the healing process . ph measurement : the ph induced for the formulations of the mixtures was determined with the ph universal meter ( a ph meter accumeter basic ab15 / 15 ). such tests were made at a temperature of 22 ° c . and a relative humidity of 100 %. before each measurement , the ph meter was calibrated with ph patterns dissolutions . the maximum value to which the material is disintegrated was determined through the use of test tubes which dimensions are 9 mm diameter and 18 mm length , wherein the different mixtures of the biocomposite were placed and after its setting a machine velocity of 1 mm / min was applied . it was recorded that the biocomposite with different proportions according to the present invention has a load tension between 2 . 100 g / cm 2 ( 2 . 1 × 10 7 g / m 2 ) and 6 . 700 g / cm 2 ( 6 . 7 × 10 7 g / m 2 ). for the study , 4 month old male new zealand bunnies were employed and with an average weight of 4 . 200 grams . 13 animals were distributed in two groups : the first one with 8 animals for histomorphometric studies and the second group with 5 animals for conducting the analysis with electronic microscopy . an incision was made on the side face of the right prominence and a surgical defect of 6 mm diameter and 3 mm depth was made with a trephine bur and fisiodispenser novoug for bone implantation . the biocomposite of the present invention was prepared , placed in situ and the tissue by planes was closed with resorbable material . the same procedure was made in the left side but leaving the defect empty . the healing was allowed for 60 days taking into account that the bone remodeling process in bunnies is of 45 days . after 60 days , the animals were sacrificed and the samples were collected by cutting the hip fragments where the surgical preparations were located . 8 double samples ( experimental and control ) and 5 double samples were randomly selected for the histomorphometric studies and the electronic microscopy studies , respectively . the histomorphometric studies showed significant differences in the histodynamics of bone formation between the two groups , the results shows a filling of 100 % in mature bone and histological remodeling after sixty days in the group treated with the biocomposite of the present invention , unlike the control group where there was only a partial filling of the defect in a 25 % of the cases and with no evidence of bone remodeling . meanwhile , the electronic microscopy studies confirm those obtained in the histomorphometric study , given that these evidence the existence of statistically significant differences in the bone formation between the experimental group treated with the biocomposite of the present invention and the control group . in fig4 and 6 it can be seen that the application of the biocomposite of the present invention aids the bone formation in the experimental defect created , which evidences an osteopromoting characteristics of the biocomposite of the present invention , unlike what is shown in fig5 and 7 corresponding to the control group , wherein it can be seen that the defect is invaded by fibrous tissue with no formation of new bone .